Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hidemi Takeshima"'
Autor:
Naoki Yoshikawa, Hidemi Takeshima, Masaaki Sekine, Keiichi Akizuki, Tomonori Hidaka, Kazuya Shimoda, Ryuji Ikeda
Publikováno v:
Pharmaceuticals, Vol 14, Iss 4, p 353 (2021)
A polymorphism in the gene encoding the metabolic enzyme cytochrome P450 family 3 subfamily A member 5 (CYP3A5) is a particularly influential factor in the use of tacrolimus in Japanese patients. Those who are homozygotic for the *3 mutation lack CYP
Externí odkaz:
https://doaj.org/article/4b9c0b28b4d740e2a00457c7f43a5a23
Autor:
Kazuya Shimoda, Masaaki Sekine, Hidemi Takeshima, Ryuji Ikeda, Naoki Yoshikawa, Keiichi Akizuki, Tomonori Hidaka
Publikováno v:
Pharmaceuticals
Volume 14
Issue 4
Pharmaceuticals, Vol 14, Iss 353, p 353 (2021)
Volume 14
Issue 4
Pharmaceuticals, Vol 14, Iss 353, p 353 (2021)
A polymorphism in the gene encoding the metabolic enzyme cytochrome P450 family 3 subfamily A member 5 (CYP3A5) is a particularly influential factor in the use of tacrolimus in Japanese patients. Those who are homozygotic for the *3 mutation lack CYP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2685fe736fa72c57486dabd361e9745a
https://doi.org/10.3390/ph14040353
https://doi.org/10.3390/ph14040353
Autor:
Takeshima, Hidemi1, Yoshikawa, Naoki1, Akizuki, Keiichi2, Hidaka, Tomonori2, Shimoda, Kazuya2, Ikeda, Ryuji1 ryuji_ikeda@med.miyazaki-u.ac.jp
Publikováno v:
Journal of Clinical Pharmacy & Therapeutics. Feb2022, Vol. 47 Issue 2, p260-262. 3p.
Autor:
Yoshikawa, Naoki1 (AUTHOR) iamhide3@med.miyazaki-u.ac.jp, Takeshima, Hidemi1 (AUTHOR) ryuji_ikeda@med.miyazaki-u.ac.jp, Sekine, Masaaki2 (AUTHOR) masaaki_sekine@med.miyazaki-u.ac.jp, Akizuki, Keiichi2 (AUTHOR) keiichi_akizuki@med.miyazaki-u.ac.jp, Hidaka, Tomonori2 (AUTHOR) tmnhdk@med.miyazaki-u.ac.jp, Shimoda, Kazuya2 (AUTHOR) kshimoda@med.miyazaki-u.ac.jp, Ikeda, Ryuji1 (AUTHOR)
Publikováno v:
Pharmaceuticals (14248247). Apr2021, Vol. 14 Issue 4, p353. 1p.